Vinkristin

Vinkristin
Klinički podaci
Prodajno ime	Marqibo, Onco TCS, Oncovin, Vincasar
Drugs.com	Monografija
Način primene	Intravenozno
Identifikatori
CAS broj	57-22-7
ATC kod	L01CA02 (WHO)
PubChem	CID 5978
DrugBank	DB00541
ChemSpider	5758
KEGG	C07204
ChEBI	CHEBI:28445
ChEMBL	CHEMBL303560

Vinkristin je organsko jedinjenje, koje sadrži 46 atoma ugljenika i ima molekulsku masu od 824,958 Da.^[1]^[2]^[3]^[4]^[5]

Osobine

Osobina	Vrednost
Broj akceptora vodonika	12
Broj donora vodonika	3
Broj rotacionih veza	10
Particioni koeficijent^[6] (ALogP)	4,0
Rastvorljivost^[7] (logS, log(mol/L))	-6,7
Polarna površina^[8] (PSA, Å²)	171,2

Reference

^ Graf, W. D.; Chance, P. F.; Lensch, M. W.; Eng, L. J.; Lipe, H. P.; Bird, T. D. (април 1996). „Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A”. Cancer. 77 (7): 1356—62. PMID 8608515. doi:10.1002/(SICI)1097-0142(19960401)77:7<1356::AID-CNCR20>3.0.CO;2-#.
^ Qweider, M.; Gilsbach, J. M.; Rohde, V. (март 2007). „Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report”. J Neurosurg Spine. 6 (3): 280—3. PMID 17355029. doi:10.3171/spi.2007.6.3.280.
^ JOHNSON, I. S.; ARMSTRONG JG; GORMAN, M; BURNETT JP Jr (1963). „The Vinca Alkaloids: A New Class of Oncolytic Agents”. Cancer Research. 23: 1390—1727. PMID 14070392.
^ Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.
^ Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.
^ Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.
^ Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.
^ Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.

Literatura

Hardman JG, Limbird LE, Gilman AG (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10. изд.). New York: McGraw-Hill. ISBN 0071354697. doi:10.1036/0071422803.
Thomas L. Lemke; David A. Williams, ур. (2007). Foye's Principles of Medicinal Chemistry (6. изд.). Baltimore: Lippincott Willams & Wilkins. ISBN 0781768799.

Spoljašnje veze

Vincristine

Molimo Vas, obratite pažnju na važno upozorenje
u vezi sa temama iz oblasti medicine (zdravlja).

[1] Graf, W. D.; Chance, P. F.; Lensch, M. W.; Eng, L. J.; Lipe, H. P.; Bird, T. D. (април 1996). „Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A”. Cancer. 77 (7): 1356—62. PMID 8608515. doi:10.1002/(SICI)1097-0142(19960401)77:7<1356::AID-CNCR20>3.0.CO;2-#.

[2] Qweider, M.; Gilsbach, J. M.; Rohde, V. (март 2007). „Inadvertent intrathecal vincristine administration: a neurosurgical emergency. Case report”. J Neurosurg Spine. 6 (3): 280—3. PMID 17355029. doi:10.3171/spi.2007.6.3.280.

[3] JOHNSON, I. S.; ARMSTRONG JG; GORMAN, M; BURNETT JP Jr (1963). „The Vinca Alkaloids: A New Class of Oncolytic Agents”. Cancer Research. 23: 1390—1727. PMID 14070392.

[4] Knox, C.; Law, V.; Jewison, T.; Liu, P.; Ly, S.; Frolkis, A.; Pon, A.; Banco, K.; Mak, C.; Neveu, V.; Djoumbou, Y.; Eisner, R.; Guo, A. C.; Wishart, D. S. (2011). „DrugBank 3.0: A comprehensive resource for 'omics' research on drugs”. Nucleic Acids Research. 39 (Database issue): D1035—41. PMC 3013709 . PMID 21059682. doi:10.1093/nar/gkq1126.

[5] Wishart, D. S.; Knox, C.; Guo, A. C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. (2008). „DrugBank: A knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Research. 36 (Database issue): D901—6. PMC 2238889 . PMID 18048412. doi:10.1093/nar/gkm958.

[6] Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods”. The Journal of Physical Chemistry A. 102 (21): 3762—3772. Bibcode:1998JPCA..102.3762G. doi:10.1021/jp980230o.

[7] Tetko, I. V.; Tanchuk, V. Y.; Kasheva, T. N.; Villa, A. E. (2001). „Estimation of aqueous solubility of chemical compounds using E-state indices”. Journal of Chemical Information and Computer Sciences. 41 (6): 1488—1493. PMID 11749573. doi:10.1021/ci000392t.

[8] Ertl, P.; Rohde, B.; Selzer, P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties”. Journal of Medicinal Chemistry. 43 (20): 3714—3717. PMID 11020286. doi:10.1021/jm000942e.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

[8]

p r u Citostatici-antitumorski lekovi
Alkilirajuća sredstva	ciklofosfamid • ifosfamid • temozolomid • dakarbazin
Antimetaboliti	metotreksat • pemetreksed • kladribin • fludarabin • citarabin • fluorouracil • gemcitabin • kapecitabin
Protivtumorski antibiotici	doksorubicin • daunorubicin • idarubicin • bleomicin
Sredastva biljnog porekla	vinblastin • vinkristin • vinorelbin • etopozid • paklitaksel • docetaksel
Hormonski lekovi	megestrol • medroksiprogesteron • goserelin • triptorelin • tamoksifen • flutamid • nilutamid • bikalutamid • anastrozol • letrozol • eksemestan
Ostali najnoviji lekovi	cisplatin • karboplatin • oksaliplatin • rituksimab • alemtuzumab • cetuksimab • bevacizumab • imatinib • gefitinib • erlotinib • sorafenib • estramustin • tretinoin • bortezomib • anagrelid